Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

Presentation TCT 2024

TCT 332: Clinical and Financial Impact of an Automated vs. Manual Personal Contrast Calculator Tool to Prevent Contrast Nephropathy After Percutaneous Coronary Intervention

Presenter: Alan Zajarias

October 30, 2024

Presentation TCT 2024

TCT 327: Efficacy of High-Dose Statins on the Prevention of Contrast-Induced Nephropathy After Cardiac Catheterization: Updated Systematic Review and Meta-Analysis

Presenter: Montaser Elkholy

October 30, 2024

Presentation TCT 2019

REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs. LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

Presenter: Carlo Briguori

September 29, 2019

CIN Prevention II: Clinical Trials Summary of Completed and Ongoing Studies

Presentation TCT 2019

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

Presenter: Somjot Brar

September 28, 2019

Presentation TCT 2019

CIN Prevention II: IV Fluids

Presenter: Carlo Briguori

September 28, 2019

CIN Prevention III: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

Presentation TCT 2019

CIN Prevention I: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

Presenter: Ziad Ali

September 28, 2019

Presentation TCT 2019

CIN Risk Prediction and Outcomes

Presenter: Sripal Bangalore

September 28, 2019

Presentation TCT 2019

Contrast-Induced Nephropathy: Does It Exist and Does It Matter?

Presenter: Richard Solomon

September 28, 2019

Presentation TCT Abstracts Posters 2018

Impact of HDL to major adverse limb event in end-stage renal disease on hemodialysis due to diabetic nephropathy. from PREDICT study

Presenter: Tamon Kato

September 25, 2018

Presentation TCT 2018

Topic 6: Radial Access and AKI- What Do We Know?

Presenter: Sripal Bangalore, Somjot S. Brar

September 23, 2018

Presentation TCT 2018

Topic 5: CIN Prevention Strategies

Presenter: Sripal Bangalore, Somjot S. Brar, Roxana Mehran

September 23, 2018

Presentation TCT 2018

Topic 4: CIN Risk Prediction and Outcomes

Presenter: Sripal Bangalore, Somjot S. Brar, Hitinder S. Gurm

September 23, 2018

Presentation TCT 2018

Topic 3: Revascularization Strategies (PCI, CABG) vs Medical Therapy in Advanced CKD

Presenter: Sripal Bangalore, Somjot S. Brar

September 23, 2018

Presentation TCT 2018

Topic 2: Zero Contrast PCI

Presenter: Sripal Bangalore, Somjot S. Brar, Ziad A. Ali

September 23, 2018

Presentation TCT 2018

Topic 1: Prognostic Significance of Acute Kidney Injury After TAVR

Presenter: Sripal Bangalore, Somjot S. Brar, Steven R. Bailey

September 23, 2018

Presentation TCT 2017

Acute Kidney Injury As a PCI Quality Improvement Metric: Strengths and Weaknesses

Presenter: Somjot S. Brar, Roxana Mehran, Hitinder S. Gurm

November 01, 2017

Presentation TCT 2017

Acute Kidney Injury After TAVR: Frequency, Etiology, and Prevention

Presenter: Somjot S. Brar, Roxana Mehran, Ran Kornowski

November 01, 2017

Presentation TCT 2017

Acute Kidney Injury After PCI vs CABG: Which Is Preferred in the CKD Patient??

Presenter: Somjot S. Brar, Roxana Mehran, Anand Prasad

November 01, 2017

Presentation TCT 2017

Acute Kidney Injury in Cardiogenic Shock: Impact of Hemodynamic Support

Presenter: Somjot S. Brar, Roxana Mehran, Michael P. Flaherty

November 01, 2017

Presentation TCT 2017

Feasibility of PCI With No Contrast

Presenter: Patricia J. Best, Somjot S. Brar, Ziad A. Ali

November 01, 2017

Advertisement

TCT 332: Clinical and Financial Impact of an Automated vs. Manual Personal Contrast Calculator Tool to Prevent Contrast Nephropathy After Percutaneous Coronary Intervention

TCT 327: Efficacy of High-Dose Statins on the Prevention of Contrast-Induced Nephropathy After Cardiac Catheterization: Updated Systematic Review and Meta-Analysis

REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs. LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

CIN Prevention II: IV Fluids

CIN Prevention I: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

CIN Risk Prediction and Outcomes

Contrast-Induced Nephropathy: Does It Exist and Does It Matter?

Impact of HDL to major adverse limb event in end-stage renal disease on hemodialysis due to diabetic nephropathy. from PREDICT study

Topic 6: Radial Access and AKI- What Do We Know?

Topic 5: CIN Prevention Strategies

Topic 4: CIN Risk Prediction and Outcomes

Topic 3: Revascularization Strategies (PCI, CABG) vs Medical Therapy in Advanced CKD

Topic 2: Zero Contrast PCI

Topic 1: Prognostic Significance of Acute Kidney Injury After TAVR

Acute Kidney Injury As a PCI Quality Improvement Metric: Strengths and Weaknesses

Acute Kidney Injury After TAVR: Frequency, Etiology, and Prevention

Acute Kidney Injury After PCI vs CABG: Which Is Preferred in the CKD Patient??

Acute Kidney Injury in Cardiogenic Shock: Impact of Hemodynamic Support

Feasibility of PCI With No Contrast

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content